Status:
RECRUITING
Turkish Version of the Hammersmith Neonatal Neurological Examination (HNNE)
Lead Sponsor:
Kahramanmaras Sutcu Imam University
Collaborating Sponsors:
Gazi University
Conditions:
Cerebral Palsy (CP)
Infant ALL
Eligibility:
All Genders
37-42 years
Brief Summary
High-risk infants are defined as an infant with a history of adverse environmental and biological factors that may lead to neuromotor developmental problems. This group includes premature babies born ...
Eligibility Criteria
Inclusion
- Infants with periventricular hemorrhage, intracranial hemorrhage grades 2, 3, or 4, cystic periventricular leukomalacia (PVL), stage 3 hypoxic ischemic encephalopathy, neonatal bilirubin encephalopathy (kernicterus), perinatal stroke, perinatal asphyxia, and hydrocephalus.
- Infants with chronic lung disease, respiratory lung disease (RDS), bronchopulmonary dysplasia (BPD), and long-term oxygen supplementation.
- Preterm infants with sepsis due to gram-negative bacteria, necrotizing enterocolitis (NEC), and infantile apnea.
- Preterm infants with a low 5-minute Apgar score (3 or below), diagnosed with intrauterine growth restriction, multiple births (twins, triplets), and preterm infants with Retinopathy of Prematurity (ROP).
- Infants with prolonged severe hypoglycemia and hypocalcemia.
- Babies who are small for gestational age (SGA), less than the 3rd percentile, or large for gestational age (LGA), greater than the 97th percentile.
- Babies receiving mechanical ventilation for more than 24 hours.
- Babies born at less than 32 weeks' gestation and weighing less than 1500 grams.
Exclusion
- Babies with congenital malformations (spina bifida, congenital muscular torticollis, arthrogryposis multiplex congenita, etc.)
- Babies diagnosed with metabolic and genetic diseases (Down syndrome, spinal muscular atrophy, Duchenne muscular dystrophy, etc.)
- Babies still intubated and mechanically ventilated at 3 months postterm
Key Trial Info
Start Date :
August 22 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 15 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT07182513
Start Date
August 22 2025
End Date
March 15 2026
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kahramanmaraş Sütçü imam University
Kahramanmaraş, Onikişubat, Turkey (Türkiye), 46100